ATE44652T1 - Zubereitung mit gehalt an stabilisiertes polypeptid mit gamma-interferon aktivitaet. - Google Patents
Zubereitung mit gehalt an stabilisiertes polypeptid mit gamma-interferon aktivitaet.Info
- Publication number
- ATE44652T1 ATE44652T1 AT85105092T AT85105092T ATE44652T1 AT E44652 T1 ATE44652 T1 AT E44652T1 AT 85105092 T AT85105092 T AT 85105092T AT 85105092 T AT85105092 T AT 85105092T AT E44652 T1 ATE44652 T1 AT E44652T1
- Authority
- AT
- Austria
- Prior art keywords
- preparation containing
- gamma interferon
- interferon activity
- containing stabilized
- stabilized polypeptide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59084990A JPS60228422A (ja) | 1984-04-26 | 1984-04-26 | 安定化された生理活性物質製剤 |
EP85105092A EP0162332B1 (de) | 1984-04-26 | 1985-04-26 | Zubereitung mit Gehalt an stabilisiertes Polypeptid mit Gamma-Interferon Aktivität |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE44652T1 true ATE44652T1 (de) | 1989-08-15 |
Family
ID=13846061
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT85105092T ATE44652T1 (de) | 1984-04-26 | 1985-04-26 | Zubereitung mit gehalt an stabilisiertes polypeptid mit gamma-interferon aktivitaet. |
Country Status (5)
Country | Link |
---|---|
US (1) | US4659570A (de) |
EP (1) | EP0162332B1 (de) |
JP (1) | JPS60228422A (de) |
AT (1) | ATE44652T1 (de) |
DE (1) | DE3571552D1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5702699A (en) * | 1982-09-23 | 1997-12-30 | Cetus Corporation | Process for the recovery of lipophilic proteins |
US5643566A (en) * | 1982-09-23 | 1997-07-01 | Cetus Corporation | Formulation processes for lipophilic proteins |
US4992271A (en) * | 1982-09-23 | 1991-02-12 | Cetus Corporation | Formulation for lipophilic IL-2 proteins |
DE3687255T2 (de) * | 1985-09-10 | 1993-05-06 | Eisai Co Ltd | Einen gewebe-plasminogen-aktivator enthaltende zusammensetzung. |
DE3603444A1 (de) * | 1986-02-05 | 1987-08-06 | Thomae Gmbh Dr K | Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha |
DE3621828A1 (de) * | 1986-06-28 | 1988-01-14 | Biotest Pharma Gmbh | Stabilisierung eines fuer therapeutische zwecke, insbesondere beim menschen, bestimmten interleukin-2-praeparates sowie dieses praeparat enthaltende stabilisierte waessrige loesung oder feststoff |
JP2629000B2 (ja) * | 1986-07-18 | 1997-07-09 | 中外製薬株式会社 | 安定な顆粒球コロニー刺激因子含有製剤 |
GR871067B (en) * | 1986-07-18 | 1987-11-19 | Chugai Pharmaceutical Co Ltd | Process for producing stable pharmaceutical preparation containing granulocyte colony stimulating factor |
DE3626908A1 (de) * | 1986-08-08 | 1988-02-11 | Bayer Ag | Parenterale loesung |
US4931544A (en) * | 1986-09-04 | 1990-06-05 | Cetus Corporation | Succinylated interleukin-2 for pharmaceutical compositions |
US4944941A (en) * | 1987-08-07 | 1990-07-31 | Genentech, Inc. | Methods and compositions for the treatment of lung conditions |
US5266310A (en) * | 1987-09-17 | 1993-11-30 | Boehringer Ingelheim International Gmbh | Stabilization of therapeutically active proteins in pharmaceutical preparations |
US5151265A (en) * | 1987-11-03 | 1992-09-29 | Genentech, Inc. | Gamma interferon formulation |
JP2537935B2 (ja) * | 1987-12-29 | 1996-09-25 | 住友製薬株式会社 | 生理活性物質の農縮・脱塩方法 |
US5078997A (en) * | 1988-07-13 | 1992-01-07 | Cetus Corporation | Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers |
US5221616A (en) * | 1988-07-15 | 1993-06-22 | Quidel Corporation | Prevention of spontaneous complement activation in mammalian biological fluids |
JP2704546B2 (ja) * | 1989-04-04 | 1998-01-26 | 光利 太良 | Atll治療用吸入剤 |
DE4239877C1 (de) * | 1992-11-27 | 1994-03-17 | Boehringer Ingelheim Int | Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung |
FR2746109B1 (fr) * | 1996-03-12 | 1998-04-17 | Rhone Poulenc Rorer Sa | Milieu pour la conservation de materiel biologique |
US20030190307A1 (en) * | 1996-12-24 | 2003-10-09 | Biogen, Inc. | Stable liquid interferon formulations |
EP1569681A1 (de) * | 2002-12-13 | 2005-09-07 | Otsuka Pharmaceutical Co., Ltd. | Gefriergetrocknete zusammensetzung von gamma-interferon zur transpulmonären verabreichung und dafür geeignetes inhalationssystem |
CN100594884C (zh) * | 2008-01-07 | 2010-03-24 | 北京凯因科技股份有限公司 | 一种重组人干扰素注射剂 |
JP2010143860A (ja) * | 2008-12-19 | 2010-07-01 | Chisso Corp | タンパク質の安定化剤 |
CN102793926A (zh) * | 2011-05-20 | 2012-11-28 | 日东电工株式会社 | 可食性胶状组合物、胶状制剂以及胶状制剂的制造方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1069329B (de) * | 1959-11-19 | The National Drug Company, Philadelphia, Pa. (V. St. A.) | Verfahren zur Herstellung eines injizier'baren beständigen proteolytischen Enzympräparates | |
US4147772A (en) * | 1976-02-03 | 1979-04-03 | Merck & Co., Inc. | Vaccine stabilizer |
JPS5668607A (en) * | 1979-11-07 | 1981-06-09 | Teikoku Hormone Mfg Co Ltd | Medical preparation with storage stability |
JPS5821691A (ja) * | 1981-07-29 | 1983-02-08 | Mochida Pharmaceut Co Ltd | α−及びβ−インタ−フェロンの精製方法 |
DE3273597D1 (en) * | 1981-11-28 | 1986-11-06 | Sunstar Kk | Pharmaceutical composition containing interferon in stable state |
ZA828580B (en) * | 1981-12-23 | 1983-10-26 | Schering Corp | Interferon formulations |
JPH102519A (ja) * | 1996-06-12 | 1998-01-06 | Mitsui Eng & Shipbuild Co Ltd | 廃棄物熱分解ドラム及び熱分解方法 |
-
1984
- 1984-04-26 JP JP59084990A patent/JPS60228422A/ja active Granted
-
1985
- 1985-04-25 US US06/727,261 patent/US4659570A/en not_active Expired - Lifetime
- 1985-04-26 AT AT85105092T patent/ATE44652T1/de not_active IP Right Cessation
- 1985-04-26 EP EP85105092A patent/EP0162332B1/de not_active Expired
- 1985-04-26 DE DE8585105092T patent/DE3571552D1/de not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DE3571552D1 (en) | 1989-08-24 |
US4659570A (en) | 1987-04-21 |
JPH0481573B2 (de) | 1992-12-24 |
EP0162332B1 (de) | 1989-07-19 |
EP0162332A1 (de) | 1985-11-27 |
JPS60228422A (ja) | 1985-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE44652T1 (de) | Zubereitung mit gehalt an stabilisiertes polypeptid mit gamma-interferon aktivitaet. | |
IT8520242A0 (it) | Polipeptide umano fisiologicamente attivo. | |
AU590618B2 (en) | Stable formulation of biologically active proteins for parenteral injection | |
DE3650101D1 (de) | Analoga von Insulin und deren Herstellungsmethode. | |
DE58900341D1 (de) | Zweikammerspritze mit einer fuellung aus aktivitaetsempfindlichem humanen protein als wirkstoff. | |
BG49721A3 (en) | Method for preparing of polypeptid, their is activitty of animal hormon of growth | |
DE3689246D1 (de) | Physiologisch aktives Polypeptid BUF-3. | |
ATE103932T1 (de) | Fusionsprotein bestehend aus gm-csf und il-3. | |
ATE135405T1 (de) | Rekombinante gamma-interferonen und diese enthaltende pharmazeutische zusammensetzungen | |
LU90806I2 (fr) | Ovidrelle-choriogonadotropine alfa et ses d-riv-s pharmaceutiquement acceptables | |
ES8802235A1 (es) | Procedimiento para preparar un polipeptido | |
DK478786D0 (da) | Cystein-forarmede muteiner af biologisk aktive humantumornekrosefaktorproteiner | |
ATE31933T1 (de) | Homogenes immuninterferon-fragment. | |
DE68901098D1 (de) | Zusammensetzung aus antikoagulantia. | |
NO865191L (no) | Gm-csf-protein, derivater derav og fremstilling og anvendelse av slike proteiner. | |
DK0537166T3 (da) | Vandopløselige polypeptider med stor affinitet for alfa og beta-interferon | |
DE3486111D1 (de) | Menschliches gamma-interferonpolypeptidderivat. | |
EP0219781A3 (de) | Biologisch aktive Derivate des Human-gamma-Interferons, ihre Herstellung und Arzneimittel, die solche Derivate enthalten | |
IT1164862B (it) | Polipeptide dotato di attivita' di interferon, composizione che lo contiene e procedimento di preparazione | |
ATE109206T1 (de) | O-glycosylierter igf-1. | |
DE69106407D1 (de) | Verfahren zur Herstellung von rekombinantem menschlichem gamma-Interferon ohne Cystein und ohne Methionin am N-Terminal. | |
DK2086D0 (da) | Protraheret virkende sterilt vandigt praeparat af et peptid eller protein, dets fremstilling og anvendelse | |
IT8347559A0 (it) | Polipeptide avente attivita' di interferon, composizione che lo contiene e procedimento di preparazione | |
DE3586574D1 (de) | Menschliches gamma-interferon. | |
DE68928271D1 (de) | Polypeptid mit Isoamylase-Aktivität und seine Verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |